Skip to main content

Refine your search

ReguVa_KAKLT

HealthTech & Pharma – Opportunities and challenges of Regulations, AI and Sustainability, 27.1.2025, Kuopio

Continuing education
What are the most current topics in the regulation field of health technology and pharmaceuticals? What’s new in the regulation of AI and what does the responsible use of AI mean? How can we combine ecological, social and economic sustainability? Let’s enjoy the informative lectures and the wellness activities, all together!
smart for good
  • Social welfare and health care
  • Environment and technology
Begins:
27.1.2025
Credits:
0
Location:
Kuopio
Continuous learning category:
Social welfare and health care, Technology and digitalization
Teaching format:
Contact teaching
Price:
0 € (VAT 0%)
Jatkuva oppiminen verkkosivut

During the training day we will 

  • familiarize ourselves with the requirements and opportunities brought to the sector by the  regulation of artificial intelligence (AI).
  • learn about the responsible use of AI.
  • learn what kind of data is needed for effective and responsible decision-making.
  • discuss how we can succeed in combining ecological, social and economic sustainability at work or in everyday life. 
  • network and exchange ideas with colleagues.

In the afternoon, we will have three parallel workshops. In these workshops we get tips for sustainability actions, show how to take a next step in the regulation strategy of MDs/IVDs, and take insight into current issues in clinical studies of MDs/IVDs and pharmaceuticals. 

In addition to the informative lectures, you can promote your wellbeing and sustainability skills by participating in free wellness activities.

Register for the training day by Monday 20.1.2025 at the latest.

Come and join us in Kuopio in the closing seminar of the ReguVa project!

  • Personnel of pharmaceutical, diagnostic and health technology companies, research service companies (e.g. CROs) and pharmacies 
  • Staff of wellbeing service counties, research institutes and regulatory authorities e.g. Fimea
  • Researchers, students and staff of Universities and Universities of Applied Sciences
  • Investors 
  • Especially suitable for management, quality and regulatory affairs professionals and those responsible for public affairs

Monday,  27 January 2025, at 9.00 – 16.00.

University of Eastern Finland, Kuopio Campus Tietoteknia building, Auditorium (Savilahdentie 6 B, 70210 Kuopio) 

Registrations by 20.1.2025!

Free training. The ReguVa project is co-funded by the European Union. 

Instructor

Sandra Liede

Sandra Liede

Leading senior legal specialist

Healthtech Finland

Sandra Liede acts as the leading senior legal specialist at Healthtech Finland. She supports the association's member companies by answering their regulatory questions. She has 15 years of experience in ethical and legal issues in the health sector and a background in industry governance, law drafting and various positions of trust. Sandra has experience of working with both national and EU-level decision-makers.

Antti Kaltiainen

Antti Kaltiainen

CTO

Innokas Medical Oy

Antti Kaltiainen works as Chief Technology Officer in software development at Innokas Medical. He has 25 years of experience in various positions in software and embedded systems product development. Kaltiainen has worked the last 7 years as a CTO and advisor to companies focused on IoT and machine learning. In his work, Kaltainen follows the latest technologies and defines solutions for regulated medical software for Innokas' customers. For the past few years, he has also been an advisor on artificial intelligence in health technology in the IEC’s "Software Network and Artificial Intelligence advisory Group" under the committee of IEC TC 62.

Erkki Soini

Erkki Soini

CEO, Chairman of the Board at Kuopio Health

ESiOR Oy

Erkki Soini is a professional health economist that has extensive experience in health technology assessment, market access, real-world evidence (RWE), and secure processing environment (SPESiOR) as well as industry, health care, and public-private-partnerships. He is multiple times internationally awarded content producer in health economics, pharmacoeconomics, outcomes research, and data mining. Erkki Soini has shared expertise e.g., as an advisor in a Current Care Working Group and TEHDAS (Joint Action Towards the European Health Data Space). He has served as a scientific review committee chair of European ISPOR congress twice. His key interests include effectiveness, cost-effectiveness, and value of information. Erkki Soini has taken part in 700+ projects, 280+ public references, and 80+ scientific articles.

Kotipalo Tiina

Tiina Kotipalo

Head of Quality and Development

Medanets

Tiina Kotipalo works at Medanets Oy as the Head of Quality and Development. She has over 20 years of experience in the development, manufacturing, and quality management of medical devices, as well as in ensuring compliance with various quality and regulatory requirements. At Medanets, she leads the company’s quality processes, ensuring the safety and compliance of applications with both EU and international quality management and regulatory standards.

Ketolainen Jarkko

Jarkko Ketolainen

Head of Department, Professor

School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland

Jarkko Ketolainen (PhD Pharm, Professor in Pharmaceutical Technology since 2000 ) has been working as the Head of School at the School of Pharmacy in the University of Eastern Finland since the year 2015. He has a strong background in pharmaceutical manufacturing related process and his current research focuses on the manufacturing of solid dosage forms, with a particular emphasis on resource-efficient pharmaceutical production, such as continuous manufacturing. Furthermore, Professor Ketolainen has been a member and 2nd vice chair of the Academy of Finland’s Research Council for Health (2013 -2018). In addition, he has been a member of EUFEPS’ (European Federation for Pharmaceutical Sciences) QbD and PAT Sciences Network Steering Group since 2007. Professor Ketolainen was also the director of PROMIS Centre (a R&D centre comprised of UEF pharmacy and physics, VTT, Savonia and over 30 partnering companies international and national). Professor Ketolainen has also entrepreneurial background from late 90’s to early 2000’s (e.g. managing director of Oy MedFiles Pharma Ltd. 2000 – 2002).